产品
编 号：F001168
分子式：C20H17NO5
分子量：351.35
分子式：C20H17NO5
分子量：351.35
产品类型
规格
价格
是否有货
10mM*1mL in DMSO
询价
询价
5mg
询价
询价
10mg
询价
询价
50mg
询价
询价
100mg
询价
询价
结构图
CAS No: 1001288-58-9
产品详情
生物活性：
FT011 is an anti-fibrotic agent, reduces mRNA expression of collagens I and III and inhibits collagen synthesis. FT011 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
体内研究：
FT011 (100 mg/kg b.i.d., p.o., for 4 weeks) improves the cardiac function and and myocardial remodeling in myocardial infarction rats.Animal Model:Seventy male Sprague Dawley (SD) rats (weighing 200-250 g)
Dosage:100 mg/kg
Administration:B.I.D., p.o. on day 7 after surgery, for 4 weeks
Result:Increased ejection fraction, fraction shortening and preload recruitable stroke work.
FT011 is an anti-fibrotic agent, reduces mRNA expression of collagens I and III and inhibits collagen synthesis. FT011 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
体内研究：
FT011 (100 mg/kg b.i.d., p.o., for 4 weeks) improves the cardiac function and and myocardial remodeling in myocardial infarction rats.Animal Model:Seventy male Sprague Dawley (SD) rats (weighing 200-250 g)
Dosage:100 mg/kg
Administration:B.I.D., p.o. on day 7 after surgery, for 4 weeks
Result:Increased ejection fraction, fraction shortening and preload recruitable stroke work.
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备